Aspira Women's Health Announces $5.5 Million Registered Direct Offering and Concurrent Private Placement
Aspira Women’s Health Aspira Women’s Health (US:AWH) Newsfilter·2024-01-25 13:00

AUSTIN, Texas, Jan. 25, 2024 (GLOBE NEWSWIRE) -- Aspira Women's Health Inc. ("Aspira" or the "Company") (NASDAQ:AWH), a bio-analytical based women's health company focused on the development of gynecologic disease diagnostic tools, today announced that it has entered into definitive agreements with a single healthcare focused institutional investor alongside participation from Nicole Sandford, CEO of Aspira, as well as certain existing shareholders of the Company for the purchase and sale of 1,571,000 share ...